Insider trade

Kura Oncology (KURA)CEO sold ~$327K

Troy Edward Wilson, CEO at Kura Oncology, sold ~$327K of Kura Oncology shares.

~$327K
Approx. value · 37K sh @ $8.94
247K
Holds after · shares reported
Traded
Sep 29, 2025
Filed
Sep 29, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 13, 2025InsiderCEO purchased ~$90K of KURA shares in the open market
  2. Sep 8, 2025InsiderCEO purchased ~$410K of KURA shares in the open market
  3. Sep 29, 2025 · this disclosureInsiderCEO sold ~$327K of KURA shares in the open market

What came next

  1. Sep 29, 2025Insider · 5 peopleInsiders: 5 sales (~$371K)
  2. Nov 4, 2025Company filing · Form 8-K · ResultsReported its results
  3. Jan 11, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kura Oncology

For Kura Oncology, OQRO holds 10 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KURA page.

Other recent filings by Troy Edward Wilson, President and CEO

The full history of Troy Edward Wilson, President and CEO is on the profile page.

How this filing works

Other disclosures at Kura Oncology

Everything OQRO holds on this company is on its KURA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data